September 26th, 2018
Scott Lassman was named to this year's LMG Life Sciences’ Stars list, which recognizes outstanding U.S. legal practitioners with a focus on the life sciences industry. Mr. Lassman was recognized in the regulatory practice areas of FDA Medical Device, Healthcare Pricing & Reimbursement, and FDA Pharmaceutical law.
LMG Life Sciences evaluates attorneys on the basis of case evidence, peer feedback and client feedback.
Categories: Honors
Scott Lassman
Scott Lassman has more than 30 years’ experience in FDA law and policy, both as an in-house attorney and in private practice. He provides strategic advice and advocacy to small, mid-size and large pharmaceutical, biotechnology and medical device companies, as well as the trade associations that represent them and the investors who fund them. His practice covers all aspects of FDA regulatory law, with a special focus on exclusivity, biosimilars, product approval and policy matters...
For More Information